Credit Suisse Starts Vertex (VRTX) at Outperform, $151 PT

Credit Suisse initiates coverage on Vertex (NASDAQ: VRTX) with a Outperform rating and a price target of $151.00.

Analyst Alethia Young commented, "We are initiating coverage of Vertex with an Outperform rating and a $151 target price. Vertex has no real competition in sight, and we think its advantage is sustainable due to innovation. We also see upside with the HetMin opportunity, and it is worth $38/sh to our DCF estimate. We assume a 50% POS as we believe preclinical CF data have yielded clinical outcomes."

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $94.99 yesterday.

You May Also Be Interested In

• BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
• KKR Real Estate Financial Trust (KREF) PT Lowered to $12 at JMP Securities
• Lockheed Martin (LMT) PT Raised to $487 at Deutsche Bank